DOWNLOAD A PDF OF THIS REPORT pdf(0.1MB)
CAP’s Pharmaceutical Industry Report analyzes the executive compensation practices of 19 large pharmaceutical and biotechnology companies. As of December 31, 2015, the companies in our sample had median revenues of $23B and median market cap of $113B. In addition to reviewing the entire sample, we assessed U.S. companies (n=12) and non-U.S. companies (n=7) separately to discern trends in pay, performance and practices.
2015 Financial Results: Pharmaceutical companies experienced strong stock price appreciation and revenue growth relative to the broader market.